Public input is a key part of the drug approval process, and it occurs during hearings before FDA advisory committees, which make recommendations to support or oppose allowing a treatment to advance.
New research shows testimony given at…
Just who gets a say at FDA public drug-approval hearings? — Harvard Gazette
